Pfizer, Bristol: FDA ruling on Eliquis postponed

Federal regulators have pushed back the deadline for deciding whether to approve a highly touted experimental anticlotting drug developed jointly by Pfizer Inc.

[Ken Strong]

I believe there is a need for the US Food and Drug Administration to really look into this experimental anticlotting drug developed jointly by Pfizer Inc to avoid any kind of complication. The postponed is a good move. You may visit http://www.hiprecalllaw.com/ for more info.